Ovation.io, Inc.

Portland, ME · Founded 2017 · Biotech · Private

Genomic data platform linking population-scale genomic data with longitudinal phenotypic data for drug discovery

Claim this profile

Follows are private to you and power your alerts

Updated · ovation.io

Sector
Biotech
Headquarters
Portland, ME
Founded
2017
Latest Form D
$696K, Sep 2024
Total capital
$31.3M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$31M
4 Form D · last Sep 2024
25 months since last filing
Federal contracts
$329K
1 award · Health and Human S
Rank in Biotech#256 of 4373
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

201920202021202220232024FEDERAL ↑EQUITY ↓Cumulative $31.3M$329K2nd Form D$3.1M3rd Form D$21.3M4th Form D$696K
201920202021202220232024FEDERAL ↑EQUITY ↓Cumulative $31.3M$329K3rd Form D$21.3M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$696K
  • Federal contractHealth and Human S · Nibib Genotyping Samples For Tracking Viral Variants - Task Order 001$329K
  • Private capital raisedForm D · SEC · 3rd filing$21.3M
  • Private capital raisedForm D · SEC · 2nd filing$3.1M
  • Private capital raisedForm D · SEC · 1st filing$5.9M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Barry WarkExecutive Officer, DirectorNamed in SEC Form D filings
  • Curtis MedeirosExecutive Officer, DirectorNamed in SEC Form D filings
  • David ShawDirectorNamed in SEC Form D filings
  • John WalkerDirectorNamed in SEC Form D filings
  • Michael SelfDirectorNamed in SEC Form D filings
  • Mike SelfDirectorNamed in SEC Form D filings
Show all 12 people
  • Patrick GallagherDirectorNamed in SEC Form D filings
  • Phil FerneauDirectorNamed in SEC Form D filings
  • Soma SomasegarDirectorNamed in SEC Form D filings
  • S SomasegarDirectorNamed in SEC Form D filings
  • S. SomasegarDirectorNamed in SEC Form D filings
  • Winston BrasorExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .